Winstanley has become a transformative figure in New Haven, responsible for the $200 million 100 College Street bioscience development (informally known as “the Alexion Building” although its anchor tenant relocated its corporate headquarters to Boston almost two years ago). It represents the first phase of the city’s multi-year Downtown Crossing redevelopment project that aims to revitalize and reconnect the center-city commercial district with the medical district and Hill neighborhood. Pending final city approvals, construction will begin this August on a new structure across the street from 100 College, bearing an address that doesn’t yet exist: 101 College Street. Also scheduled to begin construction in August is a 500,000-square-foot $45 million warehouse project in Enfield with an anchor tenant already lined up, he added. That’s about $300 million in Connecticut projects scheduled to break ground within a couple of months.
https://www.hartfordbusiness.com/article/despite-covid-19-impact-developer-winstanley-still-bullish-on-cts-bioscience-industrial